| P2093 | author name string | E K Louie | |
| | L C Edwards | |
| P2860 | cites work | Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches | Q24621025 |
| | A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation | Q28258622 |
| | A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene | Q28308001 |
| | Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings | Q33151429 |
| | Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation | Q33153444 |
| | Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone | Q33158001 |
| | Natural history of hypertrophic cardiomyopathy in the elderly | Q33160724 |
| | Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants | Q33161993 |
| | Signal-averaged electrocardiography in hypertrophic cardiomyopathy | Q33161995 |
| | Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients | Q33168087 |
| | Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy | Q33169310 |
| | Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death | Q33169695 |
| | Prognosis and mortality of hypertrophic obstructive cardiomyopathy | Q33170393 |
| | Complete heart block as a cause of syncope in asymmetric septal hypertrophy | Q33171723 |
| | Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis | Q33172587 |
| | Hypertrophic cardiomyopathy: an important cause of sudden death | Q33172595 |
| | Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features | Q33173218 |
| | Familial spontaneous complete heart block in hypertrophic cardiomyopathy | Q33999135 |
| | Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy | Q34048715 |
| | An integrated mechanism for systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations | Q34191893 |
| | Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease | Q34260962 |
| | Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals | Q34565604 |
| | PRESSURE-FLOW STUDIES IN HYPERTROPHIC SUBAORTIC STENOSIS. | Q35568361 |
| | Mode of inheritance of hypertrophic cardiomyopathy in Iceland. Echocardiographic study | Q36737806 |
| | Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function | Q36749731 |
| | Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia | Q36756875 |
| | Treatment of hypertrophic obstructive cardiomyopathy with verapamil | Q36766111 |
| | Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis | Q36782521 |
| | Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment | Q36782571 |
| | Hypertrophic obstructive cardiomyopathy. Assessment by echocardiographic and Doppler ultrasound techniques | Q36790772 |
| | Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study | Q36801485 |
| | Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy | Q36915274 |
| | Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy | Q37026827 |
| | Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. | Q52432745 |
| | Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. | Q52694899 |
| | Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. | Q53678692 |
| | Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy. | Q53797373 |
| | Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. | Q53835777 |
| | Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. | Q54403965 |
| | Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. | Q54454855 |
| | Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. | Q54592223 |
| | Apical hypertrophic cardiomyopathy: evaluation by noninvasive and invasive techniques in 23 patients. | Q54596533 |
| | Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest | Q57841613 |
| | Isometric cardiac contraction. a possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis | Q67010389 |
| | Electrophysiologic findings in patients with idiopathic hypertrophic subaortic stenosis | Q67015248 |
| | Prevalence of dignostic abnormalities in patients with genetically transmitted asymmetric septal hypertrophy | Q67017886 |
| | Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients | Q67019025 |
| | Mural vegetations at the site of endocardial trauma in infective endocarditis complicating idiopathic hypertrophic subaortic stenosis | Q67019026 |
| | Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis) | Q67284589 |
| | Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy | Q70648507 |
| | Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy | Q70658788 |
| | Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients | Q70666978 |
| | Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy | Q70667298 |
| | Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy | Q70672261 |
| | Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients | Q70676010 |
| | Does outflow obstruction exist in hypertrophic cardiomyopathy? | Q70680172 |
| | Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy | Q70790072 |
| | Prognosis in hypertrophic cardiomyopathy | Q70795347 |
| | Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography | Q70799056 |
| | Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy: an echocardiographic study | Q70799060 |
| | Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment | Q70799358 |
| | Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment | Q71228887 |
| | Reversed Rivero-Carvallo's sign in right-sided hypertrophic obstructive cardiomyopathy | Q71228914 |
| | Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil | Q71230493 |
| | Obstruction within the right ventricular body: two-dimensional echocardiographic features | Q71230501 |
| | Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis | Q71230799 |
| | Two forms of hypertrophic cardiomyopathy distinguished by inheritance of HLA haplotypes and left ventricular outflow tract obstruction | Q71231832 |
| | Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy | Q71231949 |
| | Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study | Q71233565 |
| | Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility | Q71236427 |
| | Muscular subaortic stenosis. Initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man | Q72333554 |
| | Pressure gradients without obstruction. A new concept of "hypertrophic subaortic stenosis" | Q72596950 |
| | Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy) | Q72755361 |
| | The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis | Q72881805 |
| | Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse | Q93649153 |
| | Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study | Q37638509 |
| | Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population | Q38606791 |
| | The challenge of cardiomyopathy | Q38614700 |
| | Asymmetrical hypertrophy of the heart in young adults | Q39319375 |
| | Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy | Q39490561 |
| | Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease | Q39524434 |
| | Hypertensive hypertrophic cardiomyopathy of the elderly | Q39550512 |
| | Mid-ventricular obstruction: a variant of obstructive cardiomyopathy | Q39586327 |
| | Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review | Q39614414 |
| | Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). | Q39759066 |
| | Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). | Q39759074 |
| | Hypertrophic cardiomyopathy: subclassification by m mode echocardiography | Q40216960 |
| | Chordal geometry determines the shape and extent of systolic anterior mitral motion: in vitro studies | Q41304156 |
| | Determinants of exercise capacity in hypertrophic cardiomyopathy | Q41309334 |
| | Intraoperative Doppler echocardiography in hypertrophic cardiomyopathy: correlations with the obstructive gradient | Q41458405 |
| | Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy | Q42267097 |
| | Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography | Q42658697 |
| | Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis | Q43510897 |
| | The clinical course in muscular subaortic stenosis. A retrospective and prospective study of 60 hemodynamically proved cases | Q43515686 |
| | Hypertrophic cardiomyopathy characterized by marked hypertrophy of the posterior left ventricular free wall: significance and clinical implications | Q43560305 |
| | Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy | Q43655939 |
| | Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries | Q43666254 |
| | Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy | Q43871081 |
| | Risk, genotype, and cardiovascular disease | Q43905203 |
| | Hypertrophic cardiomyopathy: a 1987 viewpoint | Q43990071 |
| | Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study | Q44022316 |
| | Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates | Q44047048 |
| | Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status | Q44092122 |
| | Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy | Q44134258 |
| | Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance | Q44163223 |
| | Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy | Q44319774 |
| | Effects of diltiazem on left ventricular diastolic behavior in patients with hypertrophic cardiomyopathy: evaluation with exercise pulsed Doppler echocardiography | Q44328986 |
| | Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy | Q44448009 |
| | Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy | Q44555772 |
| | Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects | Q45018011 |
| | Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study | Q45104281 |
| | Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest | Q45291182 |
| | Hypertrophic cardiomyopathy and sudden death | Q46426968 |
| | Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy | Q46590544 |
| | Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy | Q46719808 |
| | Catenoid shape of the interventricular septum: possible cause of idiopathic hypertrophic subaortic stenosis | Q46749203 |
| | Muscular subaortic stenosis associated with complete heart block | Q47937674 |
| | Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study | Q48545553 |
| | Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis | Q50536908 |
| | Hypertrophie cardiomyopathy: A discussion of nomenclature | Q50719615 |
| | Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation | Q51280493 |
| | Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy. | Q52425515 |
| | Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy | Q67742146 |
| | Asymetric septal hypertrophy in childhood | Q67764643 |
| | Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy | Q67953091 |
| | Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration | Q67975577 |
| | Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy | Q68182672 |
| | Two types of intraventricular pressure difference in the same patient. Left ventricular catheter entrapment and right ventricular outflow tract obstruction | Q68420936 |
| | Current operative treatment of obstructive hypertrophic cardiomyopathy | Q68485142 |
| | Muscular subaortic stenosis. The direct relation between the intraventricular pressure difference and the left ventricular ejection time | Q68566233 |
| | Apical segmental dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical features | Q68625428 |
| | Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy | Q68698034 |
| | Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy | Q68717351 |
| | Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? | Q68738082 |
| | Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography | Q68832534 |
| | Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study | Q68937315 |
| | Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy | Q68979880 |
| | Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment | Q68981200 |
| | Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil | Q68994096 |
| | Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy | Q69104437 |
| | Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy | Q69400970 |
| | Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic study | Q69518052 |
| | Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS | Q69577704 |
| | Echocardiographic Measurement of the Left Ventricular Outflow Gradient in Idiopathic Hypertrophic Subaortic Stenosis | Q69578979 |
| | Left ventricular ejection dynamics and outflow obstruction in hypertrophic cardiomyopathy | Q69581100 |
| | Familial Prevalence and Genetic Transmission of Idiopathic Hypertrophic Subaortic Stenosis | Q69582981 |
| | Variations in flow-velocity waveforms obtained by pulsed Doppler echocardiography in the normal human aorta | Q69633311 |
| | Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction | Q69726380 |
| | Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy | Q69738110 |
| | Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk | Q69778174 |
| | Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1 | Q69792543 |
| | Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy | Q69882498 |
| | Patterns and timing of Doppler-detected intracavitary and aortic flow in hypertrophic cardiomyopathy | Q69887218 |
| | Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life | Q69934670 |
| | Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy | Q69934678 |
| | Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients | Q69948975 |
| | Pressure recovery distal to a stenosis: potential cause of gradient "overestimation" by Doppler echocardiography | Q69948990 |
| | Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy | Q69962140 |
| | Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy | Q70007783 |
| | Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy | Q70009698 |
| | Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy | Q70028291 |
| | Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans | Q70038243 |
| | Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy | Q70139360 |
| | Permanent pacing as treatment for hypertrophic cardiomyopathy | Q70210079 |
| | Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration | Q70228229 |
| | Muscular subaortic stenosis: the temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient | Q70475897 |
| | Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study | Q70522249 |
| | Hypertrophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography | Q70537206 |
| P433 | issue | 4 | |
| P921 | main subject | cardiomyopathy | Q847583 |
| P304 | page(s) | 275-308 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Progress in Cardiovascular Diseases | Q2635289 |
| P1476 | title | Hypertrophic cardiomyopathy | |
| P478 | volume | 36 | |